Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- PMID: 33950155
- PMCID: PMC8100911
- DOI: 10.1001/jama.2021.7489
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Abstract
This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.
Conflict of interest statement
Figures
![Figure.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8100911/bin/jama-e217489-g001.gif)
Comment in
-
COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.Transpl Infect Dis. 2021 Aug;23(4):e13649. doi: 10.1111/tid.13649. Epub 2021 Jun 13. Transpl Infect Dis. 2021. PMID: 34032340 Free PMC article. No abstract available.
-
COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford-AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India.Transplantation. 2021 Sep 1;105(9):e100-e103. doi: 10.1097/TP.0000000000003835. Transplantation. 2021. PMID: 34049359 Free PMC article.
-
Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination.Transplantation. 2021 Sep 1;105(9):e104-e106. doi: 10.1097/TP.0000000000003836. Transplantation. 2021. PMID: 34049360 No abstract available.
-
Immediate Impact of Induction Treatment on Postvaccination SARS-CoV-2 Serology in Kidney Transplant Recipients.Transplantation. 2021 Oct 1;105(10):e135-e136. doi: 10.1097/TP.0000000000003862. Transplantation. 2021. PMID: 34149002 Free PMC article. No abstract available.
-
A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient.Transpl Infect Dis. 2021 Oct;23(5):e13710. doi: 10.1111/tid.13710. Epub 2021 Aug 16. Transpl Infect Dis. 2021. PMID: 34339083 Free PMC article. No abstract available.
-
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.Dig Liver Dis. 2021 Oct;53(10):1232-1234. doi: 10.1016/j.dld.2021.07.019. Epub 2021 Jul 29. Dig Liver Dis. 2021. PMID: 34393073 Free PMC article. No abstract available.
-
The WHO is right to call a temporary halt to COVID vaccine boosters.Nature. 2021 Aug;596(7872):317. doi: 10.1038/d41586-021-02219-w. Nature. 2021. PMID: 34404945 No abstract available.
-
Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients.Transplantation. 2022 Jan 1;106(1):e103-e104. doi: 10.1097/TP.0000000000003966. Transplantation. 2022. PMID: 34699459 Free PMC article. No abstract available.
-
Renal Transplantation and Renovascular Hypertension.J Urol. 2022 Apr;207(4):915-916. doi: 10.1097/JU.0000000000002401. Epub 2022 Jan 5. J Urol. 2022. PMID: 34983189 No abstract available.
Similar articles
-
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385. JAMA. 2021. PMID: 33720292 Free PMC article.
-
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3. N Engl J Med. 2021. PMID: 33270381 Free PMC article. No abstract available.
-
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900. Transplantation. 2021. PMID: 34284420 Free PMC article. No abstract available.
-
Clinical application of COVID-19 vaccine in liver transplant recipients.Hepatobiliary Pancreat Dis Int. 2024 Aug;23(4):339-343. doi: 10.1016/j.hbpd.2023.08.010. Epub 2023 Aug 12. Hepatobiliary Pancreat Dis Int. 2024. PMID: 37620225 Review.
-
Aplastic anemia after SARS-CoV-2 infection or vaccines: case series and literature review.Blood Transfus. 2024 May;22(3):266-272. doi: 10.2450/BloodTransfus.500. Epub 2023 Sep 4. Blood Transfus. 2024. PMID: 37677091 Free PMC article. Review. No abstract available.
Cited by
-
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc Study.Vaccines (Basel). 2024 Jul 19;12(7):801. doi: 10.3390/vaccines12070801. Vaccines (Basel). 2024. PMID: 39066439 Free PMC article.
-
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine.Transpl Int. 2024 Jul 10;37:12729. doi: 10.3389/ti.2024.12729. eCollection 2024. Transpl Int. 2024. PMID: 39050189 Free PMC article.
-
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study.J Nephrol. 2024 May 23. doi: 10.1007/s40620-024-01889-9. Online ahead of print. J Nephrol. 2024. PMID: 38780697
-
Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.PLoS One. 2024 May 13;19(5):e0303420. doi: 10.1371/journal.pone.0303420. eCollection 2024. PLoS One. 2024. PMID: 38739625 Free PMC article.
-
Humoral responses to multiple SARS-CoV-2 variants after two doses of vaccine in kidney transplant patients.Virulence. 2024 Dec;15(1):2351266. doi: 10.1080/21505594.2024.2351266. Epub 2024 May 8. Virulence. 2024. PMID: 38717195 Free PMC article.
References
-
- Patel EU, Bloch EM, Clarke W, et al. . Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers. J Clin Microbiol. Published online January 21, 2021. doi:10.1128/JCM.02257-20 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous